Anti-CD19 antibody therapy for autoimmune disease

Details for Australian Patent Application No. 2006244445 (hide)

Owner Duke University

Inventors Tedder, Thomas F.; Hamaguchi, Yasuhito; Yazawa, Norihito; Gron, Hanne

Agent Shelston IP

Pub. Number AU-A-2006244445

PCT Pub. Number WO2006/121852

Priority 60/679,095 05.05.05 US

Filing date 5 May 2006

Wipo publication date 16 November 2006

International Classifications

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61K 39/40 (2006.01) Medicinal preparations containing antigens or antibodies - bacterial

A61K 51/00 (2006.01) Preparations containing radioactive substances for use in therapy or testing

C07K 16/00 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C12P 21/08 (2006.01) Preparation of peptides or proteins - Monoclonal antibodies

C07K 17/00 (2006.01) Carrier-bound or immobilised peptides

Event Publications

13 December 2007 PCT application entered the National Phase

  PCT publication WO2006/121852 Priority application(s): WO2006/121852

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006244446-Combination therapy with sulodexide and a blood pressure reducing agent in the treatment of diabetic nephropathy

2006244427-Bulk enhancing forming fabrics